Leading research institutions are actively studying NAD+ for longevity. Here’s what they’re finding.
Harvard Medical School (Dr. David Sinclair) Key Findings NMN reversed age-related vascular dysfunction in mice Restored muscle NAD+ levels to youthful levels Improved exercise capacity in aged animals Enhanced blood flow through capillary formation Current Research Human clinical trials on NMN and aging biomarkers Studies on NMN and cardiovascular health Research on optimal dosing protocols MIT (Dr. Leonard Guarente) Key Findings Sirtuins (NAD+-dependent enzymes) regulate aging NAD+ activates sirtuins, promoting cellular health Resveratrol enhances sirtuin activation NAD+ decline is a hallmark of aging Current Research NAD+ and neurodegeneration Sirtuin biology NAD+ precursor combinations University of Washington (Dr. Shin-ichiro Imai) Key Findings NMN improved insulin sensitivity in aged mice Enhanced immune function Improved eye function Restored gene expression patterns to younger profiles Current Research Long-term NMN safety in humans NMN and age-related diseases Optimal NMN formulations Other Notable Research Mayo Clinic Senolytics + NAD+ precursors for aging Combined interventions for longevity Karolinska Institute NAD+ and mitochondrial diseases NR clinical applications University of Cambridge NAD+ and neurodegeneration Brain-specific NAD+ metabolism Where the Science is Heading Near-term (1-3 years) More human clinical trials Better understanding of optimal dosing Personalized NAD+ protocols Medium-term (3-10 years) FDA-approved anti-aging interventions Combination therapies Biomarker-guided supplementation Long-term (10+ years) Potential lifespan extension interventions Disease prevention protocols Precision longevity medicine Related Articles NAD+ and Aging NMN & NR Research: Latest Clinical Trials Best NAD+ Supplements in 2026